sniffing (figure). He was managed by aspiration of the air under local anesthesia with a 24-gauge needle. The emphysema resolved within 24 hours, and the patient experienced no persistent problems.
Orbital complications secondary to endoscopic sinus surgery include extraorbital muscle damage, nasolacrimal duct or sac injury, optic nerve injury, and intraorbital hemorrhage or emphysema. 1 The most common complication reported in a nationwide British audit of sinus surgery was orbital fat exposure. 2 Periorbital emphysema occurs secondary to a breach of the lamina papyracea during sinus surgery and the subsequent ingress of air from the nasal cavity and/or sinuses. Periorbital emphysema can generally be man- where it has decided to cover the Watch-PAT for home diagnosis of obstructive sleep apnea.
This decision will make the Watch-PAT available to Medicare beneficiaries nationwide.
The CMS Final Decision Memorandum discussed the Watch-PAT and the clinical evidence supporting its efficacy in very positive detail. Of particular note is CMS's response to comments that asserted that the Watch-PAT is a useful diagnostic tool and should not be required to provide additional data under Coverage with Evidence Development.
"Today's decision will mean that Medicare beneficiaries in the United States will have access to one of the most accurate, convenient, and cost-effective home sleep testing diagnostic device for sleep apnea," said ltamar Medical CEO Israel Schreiber. "Medicare now joins the Department of Veterans Affairs, Kaiser Permanente, and other organizations and physicians nationwide in recognizing the usefulness and benefits of Watch-PAT in the diagnosis of sleep apnea."
In its announcement, ltamar Medical was pleased to have found that the CMS singled out the Watch-PAT and distinguished it from others by creating a special category to fit this unique technology. Medicare will not cover devices that are considered to be Level IV devices with one or two channels. This means that physicians will be reimbursed by Medicare for using the Watch-PAT to diagnose obstructive sleep apnea in Medicare beneficiaries and for any subsequent CPAP therapy ordered based on the Watch-PAT results.
"The Watch-PAT is already a widely used home sleep testing device and this coverage decision means that all Medicare beneficiaries suspected of having obstructive sleep apnea will have access to a device that was designed to provide uniquely convenient and comfortable use with proven accurate and reliable performance," said Gary J. Sagiv, ltamar Medical Inc's Vice President.
CMS will now issue instructions to the local insurance companiesthat home sleep testing with the Watch-PAT should be paid when it is medically necessary. ltamar will be working with CMS to obtain a temporary code (G code) to describe the Watch-PAT until a permanent Category I CPT code is approved. ltamar Medical has already submitted a CPT application for the June meeting of the CPT Panel.
For more information about ltamar Medical Inc. please contact:
ltamar Medical Inc. aged conservatively as long as close attention is paid to visual acuity; any deterioration should be addressed.1. 3 Although orbital emphysema is often self-limiting, the risk of visual loss secondary to a compartment syndrome is significant. 4 • 7 A staging system and treatment algorithm based on a series of 8 patients and a literature review has been described by Hunts et al. 4 Needle aspiration of orbital or periorbital emphysema has been previously described as a useful aid to recovery or resolution of acute compression. 4 • 8 Any surgeon operating in this area of the eye must be aware of the potential complications and know how to deal with them should they arise. Patients should be instructed to avoid nose-blowing, sniffing, and Valsalva maneuvers during the postoperative period.
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